LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

Home・Список акций・aTyr Pharma Inc

aTyr Pharma Inc

Закрыт

5.27 -3.13

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

5.17

Макс.

5.59

Ключевые показатели
By Trading Economics
Доход	-4.7M -20M

Рекомендации
By TipRanks
Рекомендации	Активная покупка
Прогноз на 12 месяцев	+295.05% upside

aTyr Pharma Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

9 сент. 2025 г., 23:37 UTC

Популярные акции

Stocks to Watch: Oracle, Wearable Devices, GameStop

9 сент. 2025 г., 20:41 UTC

Отчет

Oracle's Backlog Surges With Major Customer Deals in 1Q

9 сент. 2025 г., 20:30 UTC

Отчет

GameStop 2Q Sales, Profit Rise

9 сент. 2025 г., 23:19 UTC

Обсуждения рынка

ANZ Adds a Further 50 Bps in FOMC Cuts to Outlook -- Market Talk

9 сент. 2025 г., 21:35 UTC

Отчет

Oracle Stock Soars on Strong AI Backlog. Earnings Were Good Enough. -- Barrons.com

9 сент. 2025 г., 21:32 UTC

Отчет

Oracle's Backlog Swells With Big Customer Deals -- Update

9 сент. 2025 г., 21:02 UTC

Приобретения, слияния, поглощения

DHL Adds to Healthcare Logistics Services With Acquisition -- Update

9 сент. 2025 г., 20:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

9 сент. 2025 г., 20:33 UTC

Отчет

These Stocks Moved the Most Today: Apple, UnitedHealth, Nebius, Wolfspeed, Tourmaline Bio, Albemarle, Dell, and More -- Barrons.com

9 сент. 2025 г., 20:26 UTC

Отчет

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9 сент. 2025 г., 20:23 UTC

Отчет

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9 сент. 2025 г., 20:12 UTC

Отчет

Oracle Stock Jumps on Mixed Earnings Report -- Barrons.com

9 сент. 2025 г., 20:10 UTC

Отчет

Oracle Expects Cloud Infrastructure Rev to Grow 77% to $18 B This Fiscal Yr >ORCL

9 сент. 2025 г., 20:10 UTC

Отчет

Oracle Expects to Sign-Up Several Additional Multi-B-dollar Customers and RPO Is Likely to Exceed Half-A-Trillion Dollars Over Next Few Mos

9 сент. 2025 г., 20:09 UTC

Отчет

Synopsys Sees 4Q Adj EPS $2.76-Adj EPS $2.80 >SNPS

9 сент. 2025 г., 20:09 UTC

Отчет

Synopsys Sees 4Q Loss/Shr 16c-Loss 27c >SNPS

9 сент. 2025 г., 20:08 UTC

Отчет

Oracle 1Q Short-term Deferred Rev Were $12.1 B >ORCL

9 сент. 2025 г., 20:08 UTC

Отчет

Oracle 1Q Operating Income Was $4.3 B >ORCL

9 сент. 2025 г., 20:08 UTC

Отчет

Oracle Expects MultiCloud Rev to Grow Substantially Every Qtr for Several Years >ORCL

9 сент. 2025 г., 20:08 UTC

Отчет

Synopsys Sees 4Q Rev $2.23B-$2.26B >SNPS

9 сент. 2025 г., 20:07 UTC

Отчет

Oracle Total Remaining Performance Obligations Up to $455 B >ORCL

9 сент. 2025 г., 20:06 UTC

Отчет

Oracle 1Q Software Revenue $5.72B >ORCL

9 сент. 2025 г., 20:06 UTC

Отчет

Synopsys 3Q Adj EPS $3.39 >SNPS

9 сент. 2025 г., 20:06 UTC

Отчет

Oracle 1Q Cloud Revenue $7.19B >ORCL

9 сент. 2025 г., 20:05 UTC

Отчет

Oracle 1Q Rev $14.93B >ORCL

9 сент. 2025 г., 20:05 UTC

Отчет

Oracle 1Q EPS $1.01 >ORCL

9 сент. 2025 г., 20:05 UTC

Отчет

Synopsys 3Q EPS $1.50 >SNPS

9 сент. 2025 г., 20:05 UTC

Отчет

Oracle 1Q Services Revenue $1.35B >ORCL

9 сент. 2025 г., 20:05 UTC

Отчет

Oracle 1Q Adj EPS $1.47 >ORCL

9 сент. 2025 г., 20:05 UTC

Отчет

Oracle 1Q Hardware Revenue $670M >ORCL

Сравнение c конкурентами

Изменение цены

aTyr Pharma Inc Прогноз

Целевая цена

By TipRanks

295.05% рост

Прогноз на 12 месяцев

Средняя 21.57 USD 295.05%

Максимум 35 USD

Минимум 16 USD

Основано на мнении 8 аналитиков Wall Street, спрогнозировавших целевые цены для aTyr Pharma Inc на следующие 12 месяцев – Данные за последние 3 месяца.